- General Questions
- Technology Transfer and Commercialization
- Disclosing an Invention
- Protecting Intellectual Property
- Patenting and Licensing
- Glossary
If you have additional questions regarding intellectual property, patenting, or commercialization, please contact the UAH OTC by email at otc@uah.edu or by calling 256.824.6620.
General Questions
Patenting decisions are not based solely on technical potential. Intellectual property judged as offering reasonable commercial potential will be considered for further processing. In order to recoup appropriate return on its investment, the University evaluates disclosures on anticipated ability to patent, license, and market IP before making a patent decision.
It is never too early to call OTC for advice on disclosure. As an inventor, it is to your advantage to involve OTC early on as you embark on your research or to disclose your ideas as soon as you have a clear concept of your invention or discovery. Conception of the invention means that you should be able to clearly explain how the invention will work. Completed experiments are helpful but not necessary.
To protect the patentability of your invention, you should disclose it to OTC before you publish any information about the invention, even if referencing only a part of the entire invention. Posters, seminar presentations, abstracts, internet publications of funded grants, or articles in local publications can disclose enough of an invention to prevent you from obtaining a patent. These are called public disclosures.
If you expect to present or publish your research, be sure to submit an Intellectual Property Disclosure (IPD) form well in advance to allow time for the evaluation process. It is possible that a provisional patent application can be filed to protect your invention for one year. If a patent application is not filed before a public disclosure, foreign rights will be forfeited. If a U.S. patent is not filed within a year, U.S. rights will also be forfeited.
The OTC keeps records of inventor activities. Please email us at otc@uah.edu to obtain copies of this information.
Technology Transfer and Commercialization
Technology transfer refers to the process of sharing or transferring knowledge, expertise, and technologies from one organization, individual or country to another, with the goal of promoting innovation and development. This transfer can occur between government agencies, universities, research institutions, private companies, or individuals.
The aim of technology transfer is to enable the recipient to acquire the necessary knowledge, skills, and resources to improve their technological capabilities, increase their competitiveness, and enhance their economic growth. Technology transfer can occur through licensing agreements, joint ventures, partnerships, or collaborations between organizations.
University technology transfer describes the process of ensuring that promising technologies developed from university research are translated into successful commercial ventures that benefit society. To facilitate and accelerate this process, universities establish technology transfer/technology commercialization offices such as UAH OTC.
The basic steps in the commercialization process are:
- Innovator Education
- Innovation
- Disclosure
- Triage
- Market Analysis
- Intellectual Property Protection
- Marketing
- Licensing
- Revenue Generation
Act of 1980," is a United States federal law that governs the ownership and licensing of inventions and technologies that are developed with the use of federal funding.
Prior to the passage of the Bayh-Dole Act, the ownership of inventions and technologies developed through federal funding was retained by the government, which often led to bureaucratic delays and a lack of incentives for universities and small businesses to commercialize their discoveries. The Bayh-Dole Act changed this by allowing universities, small businesses, and non-profit institutions to retain ownership of their inventions and technologies that were developed with federal funding.
The significance of the Bayh-Dole Act is that it has helped to spur innovation and commercialization of research by allowing universities and small businesses to control the intellectual property developed with federal funding. This has led to increased collaboration between academia and industry, as well as a greater emphasis on the commercialization of scientific discoveries and innovations.
The Bayh-Dole Act has been credited with creating new industries, generating jobs, and increasing the economic competitiveness of the United States. It has also served as a model for other countries looking to promote technology transfer and innovation.
Commercializing your idea at an academic institution can offer several benefits, including access to funding, expertise, personal income growth, and intellectual property protection. Academic institutions also offer networking opportunities with entrepreneurs, investors, and industry leaders. Finally, commercializing your idea can allow you to make a positive impact on society by bringing new products or services to market that can improve people's lives, create jobs, and stimulate economic growth.
Disclosing an Invention
After an Intellectual Property Disclosure (IPD) form submission, the submitter will receive an email acknowledging the submission has been received. Other people listed on the IPD, including any other inventors and the first inventor’s supervisor, will receive emails requesting review and acknowledgement of IPD submission. Additionally, if applicable, information about the funding source(s) from the Office of Sponsored Programs (OSP) will be requested and obtained. Then, OTC will process the IPD to ensure all necessary information is included on the IPD. The submitter will be contacted at this point if there is any missing/incomplete information. After successful processing of the IPD, the submitter will receive an email confirming the successful processing of the IPD and an internal IPD docket number. Then, OTC will schedule an initial meeting with the innovators to discuss next steps on the Pathway to Commercialization.
UAH innovators should disclose any innovation for which it may be worth pursuing intellectual property protection as soon as possible. The earlier, the better. A working prototype is not required for disclosure.
Disclosure should occur before submission of a manuscript, presentation of research, or publication of work. In short, disclosure should occur before any pending public disclosure.
Disclosure timing is critical to the commercialization process. UAH OTC can help innovators determine proper disclosure timing.
UAH researchers, faculty, and students have a duty to disclose new innovations; Innovation disclosure is a university policy. Any innovation developed during employment with UAH is assigned to The Board of Trustee for the University of Alabama System, as per Board Rule 509. Disclosure is also required by federal agencies.
Furthermore, intellectual property disclosure is an important step in the pathway to commercialization so that OTC can seek intellectual property protection and develop a commercialization strategy.
To submit an Intellectual Property Disclosure (IPD) form, you must be a UAH faculty, employee, or student. The IPD form is accessed through UAH’s Single Sign-On (SSO). The submitter of the form does not have to be the PI. If you have trouble accessing or submitting the digital form or have questions, please contact our office at otc@uah.edu
OTC has the responsibility of informing any funding agency. Federal agency funding should be listed in the disclosure, and it is OTC’s responsibility to report to the federal funding agency. This is part of the requirements of the Bayh-Dole Act, which standardized the invention disclosure process so that federal agencies had one point of contact instead of dealing with multiple individual PI’s. When a federal agency hires an inventor, the university has the first right to take ownership of the invention. However, under Board Rule 509, all intellectual property created by employees of UAH, is immediately owned by the University upon creation.
Yes, the new information should be submitted to OTC with a new Intellectual Property Disclosure (IPD) form form. The improvement to an invention could require a separate patent application or help support the patent prosecution of a previous patent application.
In the context of US patent law, a public disclosure refers to any communication or publication of an invention that makes the information available to the public. This can include any type of disclosure, such as a written description, a presentation, a product demonstration, or even a sale of the invention. It would also include online and print abstracts of federally funded proposals, abstracts submitted to conferences, presentations at conferences/symposiums, graduate theses, dissertation presentations, and doctoral papers, and any other online posting such as discussion board or lab website.
Under US patent law, a public disclosure can have significant implications for the ability to obtain a patent. In general, a public disclosure of an invention prior to filing a patent application can be detrimental, as it may invalidate the novelty and non-obviousness requirements of patentability. Avoid discussing enabling details about your discovery with anyone apart from your research team without a Confidential Disclosure Agreement (CDA).
Public disclosure is based on the public’s ability to access it and that it was made available. If you are planning a public disclosure or if you have any questions or concerns about whether an activity may constitute a public disclosure, please contact OTC to ensure necessary steps are taken to protect the patentability of your invention.
An inventor is anyone who’s contribution to the invention gives rise at least one claim in the patent or who is considered an author on the copyright. On the Intellectual Property Disclosure (IPD) form, include anyone (UAH and non-UAH affiliated) that has contributed to the invention’s creation. The IPD should be filled out as fully and completely as possible. When OTC processes the IPD, further details on the innovation disclosure may need clarification or agreement by the inventor(s).
Yes, the disclosure form can be used for all copyrightable matters, as well as patentable inventions.
If you think you might have intellectual property (IP) to disclose to the University, please contact the Office of Technology Commercialization (OTC) as soon as possible by email at otc@uah.edu or by calling 256.824.6712.
Protecting Intellectual Property
Although the originator of a protectable idea is the inventor, all rights to IP created by UAH employees, or individuals who use UAH resources to assist in developing the IP, are owned by the University. Income from successful commercialization is distributed according to the UAH Patent Policy.
Any innovation or intellectual property developed at UAH will still be owned by UAH. Innovators will continue to receive royalty payments according to University policy.
One of the best ways to protect the patentability of your IP is by thoroughly documenting the discoveries, experiments, etc. related to the development of your invention. The first step is to keep good lab notes.
Patent applications in the United States can be filed with the United States Patent and Trademark Office (USPTO). The USPTO is a federal agency responsible for granting patents and registering trademarks.
In the United States, copyrights are registered with the United States Copyright Office, which is a part of the Library of Congress.
The UAH Copyright Policy, UAH Patent Policy, and UAH IP Revenue Distribution Policy can be found and downloaded here.
Patenting and Licensing
In general, for a subject matter to be eligible for a patent, it must meet several criteria, including:
- Utility: The invention must have a useful purpose and provide a practical benefit to society.
- Novelty: The invention must be new and not previously disclosed or made available to the public.
- Non-obviousness: The invention must not be obvious to a person having ordinary skill in the relevant field.
- Enablement: The patent application must provide enough information to enable a person having ordinary skill in the relevant field to make and use the invention.
- Written description: The patent application must include a written description of the invention, including enough detail to show that the inventor has possession of the claimed invention.
Additionally, certain subject matter may be ineligible for patent protection, including laws of nature, natural phenomena, and abstract ideas. In general, the subject matter must be a tangible, concrete invention that is not simply an idea or a theory.
It is important to note that the criteria for patentability can be complex and may vary depending on the jurisdiction and the type of invention.
The University’s IP evaluation process can usually take several days to months, depending on the complexity of the invention. Once a patent application is filed, it can take from one to three years (or in some cases, more) for the patent to be issued or denied by the USPTO.
The cost to file a United States patent application ranges from approximately $9,000 to $12,000. Prosecution and issuance fees cost several thousand dollars more, depending upon the complexity of the invention. International patents are significantly more expensive. Additionally, both U.S. and foreign patent offices charge fees to maintain the patent over its life..
Patents are an important tool for protecting intellectual property, encouraging innovation, monetizing inventions, and gaining a competitive advantage. They play a crucial role in promoting progress and economic growth by incentivizing inventors to invest in research and development and bring new products and services to market.
An IP license is a legal agreement between the owner of the IP and another party, allowing that party to use, manufacture, sell, or otherwise exploit the IP. In exchange for the license, the licensee typically pays the IP owner a royalty or licensing fee.
IP licenses can take many forms, ranging from exclusive licenses (where the licensee has exclusive rights to the IP) to non-exclusive licenses (where the licensee shares rights with other licensees). The terms of the license are typically negotiated between the parties and may include restrictions on the licensee's use of the IP, such as geographic or time limitations.
A patent license can be an effective way for the IP owner to monetize their patents by allowing others to use their IP in exchange for compensation. It can also be a way to bring new products and services to market by allowing others to use the IP in their own products or services. For licensees, an IP license can provide access to valuable technology and competitive edge that might otherwise be difficult or expensive to develop independently.
IP license is a valuable tool for both patent owners and licensees, allowing them to benefit from the invention and promote innovation and progress.
